Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bernstein Upgrades Equinor to Outperform

Bernstein analyst Oswald Clint upgrades Equinor (NYSE:EQNR) from Market Perform to Outperform.
byBenzinga Newsdesk
January 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bernstein analyst Oswald Clint upgrades Equinor (NYSE:EQNR) from Market Perform to Outperform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Arcutis Presents New Long-Term Data Of Roflumilast Cream 0.15% For The Treatment Of Mild To Moderate Atopic Dermatitis In Adults And Children Down To Age 6 At The Revolutionizing Alopecia Areata, Vitiligo, And Eczema Conference

By Benzinga Newsdesk
June 10, 2:32 PM
Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment 66.2% of participants treated with once-daily roflumilast cream

ARQT